These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24446123)

  • 41. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells.
    Kao CL; Tai LK; Chiou SH; Chen YJ; Lee KH; Chou SJ; Chang YL; Chang CM; Chen SJ; Ku HH; Li HY
    Stem Cells Dev; 2010 Feb; 19(2):247-58. PubMed ID: 19656070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming.
    Yokota M; Hatakeyama H; Okabe S; Ono Y; Goto Y
    Hum Mol Genet; 2015 Aug; 24(16):4698-709. PubMed ID: 26025377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium.
    Hayashi R; Ishikawa Y; Ito M; Kageyama T; Takashiba K; Fujioka T; Tsujikawa M; Miyoshi H; Yamato M; Nakamura Y; Nishida K
    PLoS One; 2012; 7(9):e45435. PubMed ID: 23029008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defects in mitochondrial DNA replication and oxidative damage in muscle of mtDNA mutator mice.
    Kolesar JE; Safdar A; Abadi A; MacNeil LG; Crane JD; Tarnopolsky MA; Kaufman BA
    Free Radic Biol Med; 2014 Oct; 75():241-51. PubMed ID: 25106705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming.
    Kang L; Wu J; Tao Y; Li H; Liu X; Gao S; Wang QF
    Stem Cells Dev; 2015 Jun; 24(12):1483-92. PubMed ID: 25751301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transient folate deprivation facilitates the generation of mouse-induced pluripotent stem cells.
    Yan Q; Xu J; Hu W; Li Z; Wu J; Zhang S
    Cell Biol Int; 2014 May; 38(5):571-6. PubMed ID: 24375975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.
    Zhang X; Li S; Yang W; Pan H; Qin D; Zhu X; Yan Q
    Methods Mol Biol; 2016; 1353():323-42. PubMed ID: 25646615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced expression of Paternally Expressed Gene-3 enhances somatic cell reprogramming through mitochondrial activity perturbation.
    Theka I; Sottile F; Aulicino F; Garcia AC; Cosma MP
    Sci Rep; 2017 Aug; 7(1):9705. PubMed ID: 28852087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ATG3-dependent autophagy mediates mitochondrial homeostasis in pluripotency acquirement and maintenance.
    Liu K; Zhao Q; Liu P; Cao J; Gong J; Wang C; Wang W; Li X; Sun H; Zhang C; Li Y; Jiang M; Zhu S; Sun Q; Jiao J; Hu B; Zhao X; Li W; Chen Q; Zhou Q; Zhao T
    Autophagy; 2016 Nov; 12(11):2000-2008. PubMed ID: 27575019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction.
    Ahlqvist KJ; Leoncini S; Pecorelli A; Wortmann SB; Ahola S; Forsström S; Guerranti R; De Felice C; Smeitink J; Ciccoli L; Hämäläinen RH; Suomalainen A
    Nat Commun; 2015 Mar; 6():6494. PubMed ID: 25751021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation.
    Nishimura K; Aizawa S; Nugroho FL; Shiomitsu E; Tran YTH; Bui PL; Borisova E; Sakuragi Y; Takada H; Kurisaki A; Hayashi Y; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2017 Mar; 8(3):787-801. PubMed ID: 28262547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial remodeling in hepatic differentiation and dedifferentiation.
    Wanet A; Remacle N; Najar M; Sokal E; Arnould T; Najimi M; Renard P
    Int J Biochem Cell Biol; 2014 Sep; 54():174-85. PubMed ID: 25084555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation.
    Chen T; Yuan D; Wei B; Jiang J; Kang J; Ling K; Gu Y; Li J; Xiao L; Pei G
    Stem Cells; 2010 Aug; 28(8):1315-25. PubMed ID: 20521328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells.
    Hung SS; Van Bergen NJ; Jackson S; Liang H; Mackey DA; Hernández D; Lim SY; Hewitt AW; Trounce I; Pébay A; Wong RC
    Aging (Albany NY); 2016 May; 8(5):945-57. PubMed ID: 27127184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation.
    Fujikura J; Nakao K; Sone M; Noguchi M; Mori E; Naito M; Taura D; Harada-Shiba M; Kishimoto I; Watanabe A; Asaka I; Hosoda K; Nakao K
    Diabetologia; 2012 Jun; 55(6):1689-98. PubMed ID: 22396012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.
    Palombo F; Peron C; Caporali L; Iannielli A; Maresca A; Di Meo I; Fiorini C; Segnali A; Sciacca FL; Rizzo A; Levi S; Suomalainen A; Prigione A; Broccoli V; Carelli V; Tiranti V
    Stem Cell Reports; 2021 Aug; 16(8):1953-1967. PubMed ID: 34329598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of mitochondrial DNA mutations in human induced pluripotent stem cells.
    Carelli V; Hirano M; Enríquez JA; Chinnery PF
    Nat Rev Genet; 2022 Feb; 23(2):69-70. PubMed ID: 34728812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induced pluripotent stem cells (iPSCs) for modeling mitochondrial DNA disorders.
    Prigione A
    Methods Mol Biol; 2015; 1265():349-56. PubMed ID: 25634286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.